Literature DB >> 19737019

Acquisition of a potent and selective TC-PTP inhibitor via a stepwise fluorophore-tagged combinatorial synthesis and screening strategy.

Sheng Zhang1, Lan Chen, Yong Luo, Andrea Gunawan, David S Lawrence, Zhong-Yin Zhang.   

Abstract

Protein tyrosine phosphatases (PTPs) regulate a broad range of cellular processes including proliferation, differentiation, migration, apoptosis, and immune responses. Dysfunction of PTP activity is associated with cancers, metabolic syndromes, and autoimmune disorders. Consequently, small molecule PTP inhibitors should serve not only as powerful tools to delineate the physiological roles of these enzymes in vivo but also as lead compounds for therapeutic development. We describe a novel stepwise fluorophore-tagged combinatorial library synthesis and competitive fluorescence polarization screening approach that transforms a weak and general PTP inhibitor into an extremely potent and selective TC-PTP inhibitor with highly efficacious cellular activity. The result serves as a proof-of-concept in PTP inhibitor development, as it demonstrates the feasibility of acquiring potent, yet highly selective, cell permeable PTP inhibitory agents. Given the general nature of the approach, this strategy should be applicable to other PTP targets.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19737019      PMCID: PMC2741613          DOI: 10.1021/ja903733z

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  19 in total

Review 1.  Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development.

Authors:  Zhong-Yin Zhang
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002       Impact factor: 13.820

2.  The T cell protein tyrosine phosphatase is a negative regulator of janus family kinases 1 and 3.

Authors:  Paul D Simoncic; Ailsa Lee-Loy; Dwayne L Barber; Michel L Tremblay; C Jane McGlade
Journal:  Curr Biol       Date:  2002-03-19       Impact factor: 10.834

3.  The protein tyrosine phosphatase TCPTP suppresses the tumorigenicity of glioblastoma cells expressing a mutant epidermal growth factor receptor.

Authors:  M Klingler-Hoffmann; M T Fodero-Tavoletti; K Mishima; Y Narita; W K Cavenee; F B Furnari; H J Huang; T Tiganis
Journal:  J Biol Chem       Date:  2001-12-07       Impact factor: 5.157

4.  Identification of protein-tyrosine phosphatase 1B as the major tyrosine phosphatase activity capable of dephosphorylating and activating c-Src in several human breast cancer cell lines.

Authors:  J D Bjorge; A Pang; D J Fujita
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

5.  Regulation of insulin receptor signaling by the protein tyrosine phosphatase TCPTP.

Authors:  Sandra Galic; Manuela Klingler-Hoffmann; Michelle T Fodero-Tavoletti; Michelle A Puryer; Tzu-Ching Meng; Nicholas K Tonks; Tony Tiganis
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

Review 6.  Protein tyrosine phosphatases in the human genome.

Authors:  Andres Alonso; Joanna Sasin; Nunzio Bottini; Ilan Friedberg; Iddo Friedberg; Andrei Osterman; Adam Godzik; Tony Hunter; Jack Dixon; Tomas Mustelin
Journal:  Cell       Date:  2004-06-11       Impact factor: 41.582

7.  Potent inhibition of insulin receptor dephosphorylation by a hexamer peptide containing the phosphotyrosyl mimetic F2Pmp.

Authors:  T R Burke; H K Kole; P P Roller
Journal:  Biochem Biophys Res Commun       Date:  1994-10-14       Impact factor: 3.575

8.  Why is phosphonodifluoromethyl phenylalanine a more potent inhibitory moiety than phosphonomethyl phenylalanine toward protein-tyrosine phosphatases?

Authors:  L Chen; L Wu; A Otaka; M S Smyth; P P Roller; T R Burke; J den Hertog; Z Y Zhang
Journal:  Biochem Biophys Res Commun       Date:  1995-11-22       Impact factor: 3.575

9.  Impaired bone marrow microenvironment and immune function in T cell protein tyrosine phosphatase-deficient mice.

Authors:  K E You-Ten; E S Muise; A Itié; E Michaliszyn; J Wagner; S Jothy; W S Lapp; M L Tremblay
Journal:  J Exp Med       Date:  1997-08-29       Impact factor: 14.307

10.  Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes.

Authors:  John A Todd; Neil M Walker; Jason D Cooper; Deborah J Smyth; Kate Downes; Vincent Plagnol; Rebecca Bailey; Sergey Nejentsev; Sarah F Field; Felicity Payne; Christopher E Lowe; Jeffrey S Szeszko; Jason P Hafler; Lauren Zeitels; Jennie H M Yang; Adrian Vella; Sarah Nutland; Helen E Stevens; Helen Schuilenburg; Gillian Coleman; Meeta Maisuria; William Meadows; Luc J Smink; Barry Healy; Oliver S Burren; Alex A C Lam; Nigel R Ovington; James Allen; Ellen Adlem; Hin-Tak Leung; Chris Wallace; Joanna M M Howson; Cristian Guja; Constantin Ionescu-Tîrgovişte; Matthew J Simmonds; Joanne M Heward; Stephen C L Gough; David B Dunger; Linda S Wicker; David G Clayton
Journal:  Nat Genet       Date:  2007-06-06       Impact factor: 38.330

View more
  34 in total

1.  T cell protein tyrosine phosphatase (TCPTP) deficiency in muscle does not alter insulin signalling and glucose homeostasis in mice.

Authors:  K Loh; T L Merry; S Galic; B J Wu; M J Watt; S Zhang; Z-Y Zhang; B G Neel; T Tiganis
Journal:  Diabetologia       Date:  2011-11-29       Impact factor: 10.122

Review 2.  Protein tyrosine phosphatases and type 1 diabetes: genetic and functional implications of PTPN2 and PTPN22.

Authors:  Karen Cerosaletti; Jane H Buckner
Journal:  Rev Diabet Stud       Date:  2012-12-28

3.  Elevated hypothalamic TCPTP in obesity contributes to cellular leptin resistance.

Authors:  Kim Loh; Atsushi Fukushima; Xinmei Zhang; Sandra Galic; Dana Briggs; Pablo J Enriori; Stephanie Simonds; Florian Wiede; Alexander Reichenbach; Christine Hauser; Natalie A Sims; Kendra K Bence; Sheng Zhang; Zhong-Yin Zhang; Barbara B Kahn; Benjamin G Neel; Zane B Andrews; Michael A Cowley; Tony Tiganis
Journal:  Cell Metab       Date:  2011-10-13       Impact factor: 27.287

4.  The use of hydrogel microparticles to sequester and concentrate bacterial antigens in a urine test for Lyme disease.

Authors:  Temple A Douglas; Davide Tamburro; Claudia Fredolini; Benjamin H Espina; Benjamin S Lepene; Leopold Ilag; Virginia Espina; Emanuel F Petricoin; Lance A Liotta; Alessandra Luchini
Journal:  Biomaterials       Date:  2010-10-28       Impact factor: 12.479

5.  Substrate selection influences molecular recognition in a screen for lymphoid tyrosine phosphatase inhibitors.

Authors:  Rhushikesh A Kulkarni; Nadeem A Vellore; Matthew R Bliss; Stephanie M Stanford; Matthew D Falk; Nunzio Bottini; Riccardo Baron; Amy M Barrios
Journal:  Chembiochem       Date:  2013-08-16       Impact factor: 3.164

Review 6.  Cellular biochemistry methods for investigating protein tyrosine phosphatases.

Authors:  Stephanie M Stanford; Vanessa Ahmed; Amy M Barrios; Nunzio Bottini
Journal:  Antioxid Redox Signal       Date:  2014-02-25       Impact factor: 8.401

7.  Targeting Protein-Protein Interactions of Tyrosine Phosphatases with Microarrayed Fragment Libraries Displayed on Phosphopeptide Substrate Scaffolds.

Authors:  Megan Hogan; Medhanit Bahta; Kohei Tsuji; Trung X Nguyen; Scott Cherry; George T Lountos; Joseph E Tropea; Bryan M Zhao; Xue Zhi Zhao; David S Waugh; Terrence R Burke; Robert G Ulrich
Journal:  ACS Comb Sci       Date:  2019-01-31       Impact factor: 3.784

8.  Integrin-mediated type II TGF-β receptor tyrosine dephosphorylation controls SMAD-dependent profibrotic signaling.

Authors:  Xiwu Chen; Hongtao Wang; Hong-Jun Liao; Wen Hu; Leslie Gewin; Glenda Mernaugh; Sheng Zhang; Zhong-Yin Zhang; Lorenzo Vega-Montoto; Roberto M Vanacore; Reinhard Fässler; Roy Zent; Ambra Pozzi
Journal:  J Clin Invest       Date:  2014-07-01       Impact factor: 14.808

9.  Wedelolactone, a naturally occurring coumestan, enhances interferon-γ signaling through inhibiting STAT1 protein dephosphorylation.

Authors:  Zhimin Chen; Xiaoxiao Sun; Shensi Shen; Haohao Zhang; Xiuquan Ma; Jingli Liu; Shan Kuang; Qiang Yu
Journal:  J Biol Chem       Date:  2013-04-11       Impact factor: 5.157

10.  Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects.

Authors:  S Alice Long; Karen Cerosaletti; Paul L Bollyky; Megan Tatum; Heather Shilling; Sheng Zhang; Zhong-Yin Zhang; Catherine Pihoker; Srinath Sanda; Carla Greenbaum; Jane H Buckner
Journal:  Diabetes       Date:  2009-10-29       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.